Status:
UNKNOWN
Expression of TET1 Gene in Acute Leukaemia
Lead Sponsor:
Assiut University
Conditions:
Acute Leukemia
Eligibility:
All Genders
Brief Summary
The aim of the present study is to detect the expression of TET 1 gene in patients with acute leukemia and its correlation with clinical and pathological criteria of the patients.
Detailed Description
"Acute leukemia" is defined by the World Health organization standards, in which greater than 20% of the cells in the bone marrow are blasts (Kabuto et al., 2006). Cure is a realistic goal and is achi...
Eligibility Criteria
Inclusion
- \- sample from acute leukemia patients at diagnosis or relapse . healthy subjects as control .
Exclusion
- Patients having any other haematological malignancies.
- Patient with acute leukemia in remission
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03267485
Start Date
November 1 2017
End Date
December 1 2018
Last Update
August 30 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.